LETTER

Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo

  • Yun-Jia Ning 1 ,
  • Zhenyu Kang 1,2 ,
  • Jingjun Xing 3 ,
  • Yuan-Qin Min 4 ,
  • Dan Liu 4 ,
  • Kuan Feng 1,2 ,
  • Manli Wang 1 ,
  • Fei Deng 1 ,
  • Yiwu Zhou 1 ,
  • Zhihong Hu 1 ,
  • Hualin Wang , 1
Expand
  • 1. State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
  • 2. University of Chinese Academy of Sciences, Beijing 100049, China
  • 3. Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • 4. School of Medicine, Wuhan University of Science and Technology, Wuhan 430081, China

Published date: 27 Apr 2018

Copyright

2017 The Author(s) 2017. This article is an open access publication

Cite this article

Yun-Jia Ning , Zhenyu Kang , Jingjun Xing , Yuan-Qin Min , Dan Liu , Kuan Feng , Manli Wang , Fei Deng , Yiwu Zhou , Zhihong Hu , Hualin Wang . Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo[J]. Protein & Cell, 2018 , 9(4) : 389 -393 . DOI: 10.1007/s13238-017-0471-x

1
Baize S, Leroy EM, Georges AJ (2002) Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163–168

DOI

2
Chan SY, Ma MC, Goldsmith MA (2000) Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol 81:2155–2159

DOI

3
Cilloniz C, Ebihara H, Ni C (2011) Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 85:9060–9068

DOI

4
Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377:849–862

DOI

5
Francica JR, Matukonis MK, Bates P (2009) Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 383:237–247

DOI

6
He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509–2514

DOI

7
Jeffers SA, Sanders DA, Sanchez A (2002) Covalent modifications of the ebola virus glycoprotein. J Virol 76:12463–12472

DOI

8
Ning YJ, Deng F, Hu ZH, Wang HL (2017) The roles of ebolavirus glycoproteins in viral pathogenesis. Virol Sin 32:3–15

DOI

9
Ohimain EI (2016) Recent advances in the development of vaccines for Ebola virus disease. Virus Res 211:174–185

DOI

10
Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P (2002) Ebola virus glycoproteins induce global surface protein downmodulation and loss of cell adherence. J Virol 76:2518–2528

DOI

11
Singh G, Kumar A, Singh K, Kaur J (2015) Ebola virus: an introduction and its pathology. Rev Med Virol 26(1):49–56

DOI

12
Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y (2000) Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20–26

DOI

13
Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ (2000) Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 6:886–889

DOI

14
Zaki SR, Shieh WJ, Greer PW (1999) A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis 179:S36–S47

DOI

Outlines

/